Metadata
Author: ParaCrawl Corpus
Data
English[en]
Ben-Sasson is no stranger to the startup scene. His previous companies include Tiltan Pharma, which develops anti-cancer drugs; Chiasma, which addresses patients suffering from acromegaly (a disorder that results from excess growth hormone); and Keryx Biopharmaceuticals, which develops medicines for kidney disease.
Spanish[es]
El profesor no es ajeno al mundo de las compañías nuevas, como Tiltan Pharma, que desarrolla medicamentos contra el cáncer; Chiasma, que produce fármacos para gente con acromegalia (un trastorno debido al exceso de hormonas de crecimiento); y Keryx Biopharmaceuticals, que desarrolla fármacos para enfermedades renales.